Download presentation
Presentation is loading. Please wait.
Published byŠtěpán Vopička Modified over 5 years ago
1
Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery
Manon Haché, MD, André Denault, MD, FRCPC, Sylvain Bélisle, MD, FRCPC, Danielle Robitaille, MD, FRCPC, Pierre Couture, MD, FRCPC, Peter Sheridan, MD, FRCPC, Michel Pellerin, MD, FRCSC, Denis Babin, MSc, Nicolas Noël, BPharm, MSc, Marie-Claude Guertin, MSc, PhD, Raymond Martineau, MD, FRCPC, Jocelyn Dupuis, MD, FRCPC The Journal of Thoracic and Cardiovascular Surgery Volume 125, Issue 3, Pages (March 2003) DOI: /mtc Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions
2
Dr Haché The Journal of Thoracic and Cardiovascular Surgery , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions
3
Dr Denault The Journal of Thoracic and Cardiovascular Surgery , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions
4
Fig. 1 sPAP variations of each patient before (T1) and 10 minutes after (T2) induction of anesthesia, after nebulization of PGI2 or placebo (T3), and 15 (T4) and 25 (T5) minutes after nebulization. The Journal of Thoracic and Cardiovascular Surgery , DOI: ( /mtc ) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.